Elastic protection tube for a hollow fiber blood processing apparatus

Information

  • Patent Grant
  • 10814056
  • Patent Number
    10,814,056
  • Date Filed
    Wednesday, November 12, 2014
    10 years ago
  • Date Issued
    Tuesday, October 27, 2020
    4 years ago
Abstract
A blood processing apparatus includes a housing, a shell, a fiber bundle, and an elastic tube. The housing has a blood inlet and a blood outlet and the shell is situated in the housing and configured to receive blood through the blood inlet. The shell includes a surface and one or more apertures extending through the surface to permit the blood to flow to an exterior of the shell. The fiber bundle includes gas exchanger hollow fibers situated about the shell such that gas flows through and the blood flows across the gas exchanger hollow fibers. The elastic tube includes a fiber web situated about the fiber bundle and configured to elastically constrain and protect the gas exchanger hollow fibers during the insertion into the housing. The fiber web has a pore size that permits the blood to flow across the fiber web without filtering micro-emboli from the blood.
Description
CROSS-REFERENCE TO RELATED APPLICATION

This application is a national stage application of PCT/IB2014/065987, filed Nov. 12, 2014, which is herein incorporated by reference in its entirety.


TECHNICAL FIELD

This disclosure relates to blood processing systems and more particularly to blood processing systems that are used in blood perfusion systems.


BACKGROUND

Blood perfusion entails encouraging blood through the blood vessels of the body. Typically, blood perfusion systems include one or more pumps in an extracorporeal circuit that is interconnected with the vascular system of a patient. In cardiopulmonary bypass surgery, a blood perfusion system provides for the temporary cessation of the heart beating to create an unmoving operating field by replacing the function of the heart and lungs. Such isolation allows for the surgical correction of medical problems including vascular stenosis, valve disorders, and congenital heart defects. Blood perfusion systems used in cardiopulmonary bypass surgery have an extracorporeal blood circuit that includes at least one pump and an oxygenation device to replace the functions of the heart and lungs.


In cardiopulmonary bypass procedures, oxygen-poor blood, i.e., venous blood, is gravity-drained or vacuum suctioned from a large vein entering the heart right atrium or other veins in the body, such as the femoral vein. The oxygen-poor blood is transferred through a venous line in the extracorporeal circuit and pumped to an oxygenator that provides for oxygen transfer to the blood. The oxygen can be introduced into the blood by transfer across a microporous membrane or, less frequently, by bubbling oxygen through the blood. Concurrently, carbon dioxide is removed across the membrane. The oxygenated blood is then returned through an arterial line to the aorta, femoral artery, or another artery.


Surgeons and patients would welcome advances in blood processing systems that are used in blood perfusion systems.


SUMMARY

In some embodiments described in the disclosure, a blood processing apparatus includes a housing, a shell, a fiber bundle, and an elastic tube. The housing has a blood inlet and a blood outlet and the shell is situated in the housing and configured to receive blood through the blood inlet. The shell includes a surface and one or more apertures extending through the surface to permit the blood to flow to an exterior of the shell. The fiber bundle includes gas exchanger hollow fibers situated about the shell such that gas flows through the gas exchanger hollow fibers and the blood flows across the gas exchanger hollow fibers. The elastic tube includes a fiber web situated about the fiber bundle and configured to elastically constrain and protect the gas exchanger hollow fibers, wherein the fiber web has a pore size such that the fiber web permits the blood to flow across the fiber web without filtering micro-emboli from the blood.


In some embodiments described in the disclosure, a blood processing apparatus includes a housing, a heat exchanger, a shell, a fiber bundle, and an elastic tube. The housing has a blood inlet and a blood outlet and the heat exchanger is situated in the housing and configured to receive blood through the blood inlet and regulate the temperature of the blood. The shell is situated about the heat exchanger and includes a surface and one or more apertures extending through the surface to permit the blood to flow to an exterior of the shell. The fiber bundle includes gas exchanger hollow fibers situated about the shell such that gas flows through the gas exchanger hollow fibers and the blood flows across the gas exchanger hollow fibers. The elastic tube has a tube interior and a tube exterior such that the fiber bundle is situated in the tube interior and the tube exterior is situated next to the housing. The elastic tube elastically constrains and protects the gas exchanger hollow fibers as the fiber bundle and the elastic tube are introduced into the housing and maintained in the housing. Also, the elastic tube has an average pore size diameter with a best fit circle of greater than 200 micrometers that permits the blood to flow from the tube interior to the tube exterior without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow.


In some embodiments described in the disclosure, a method of manufacturing a blood processing apparatus includes: providing gas exchanger hollow fibers; winding the gas exchanger hollow fibers onto a shell to provide a fiber bundle on the shell; providing an elastic tube including a fiber web that permits blood to flow across the fiber web without filtering micro-emboli from the blood; introducing the fiber bundle and the shell into the elastic tube; and introducing the elastic tube containing the fiber bundle and the shell into a housing such that the fiber web elastically constrains the gas exchanger hollow fibers and protects the gas exchanger hollow fibers from being mechanically damaged by the housing during the introduction.


In some embodiments described in the disclosure, a method of pre-cleaning an elastic tube used in a blood processing apparatus includes: washing the elastic tube with a solvent; washing the elastic tube with purified water; and sterilizing the elastic tube with steam sterilization.


While multiple embodiments are disclosed, still other embodiments will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of a blood processing apparatus, in accordance with embodiments described in the disclosure.



FIG. 2 is an illustration of a first blood inlet end cap, in accordance with embodiments described in the disclosure.



FIG. 3 is an illustration of a second water in/out end cap, in accordance with embodiments described in the disclosure.



FIG. 4 is a perspective illustration of a heat exchanger core, in accordance with embodiments described in the disclosure.



FIG. 5A is a perspective illustration of a cylindrical shell that forms a barrier between a heat exchanger and a gas exchanger, in accordance with embodiments described in the disclosure.



FIG. 5B is a cross-sectional illustration of the cylindrical shell of FIG. 5A, in accordance with embodiments described in the disclosure.



FIG. 6 is a perspective illustration of the heat exchanger core of FIG. 4 disposed within the cylindrical shell of FIGS. 5A and 5B, in accordance with embodiments described in the disclosure.



FIG. 7 is a cross-sectional illustration of the blood processing apparatus of FIG. 1, in accordance with embodiments described in the disclosure.



FIG. 8 is a longitudinal cross-sectional illustration of the blood processing apparatus of FIG. 1, in accordance with embodiments described in the disclosure.



FIG. 9 is an illustration of the elastic tube in an unexpanded, relaxed condition, prior to being disposed on the fiber bundle of the blood processing apparatus, in accordance with embodiments described in the disclosure.



FIG. 10 is a microscopic enlarged illustration of a portion of the elastic tube, in accordance with embodiments described in the disclosure.



FIG. 11 is an illustration of the elastic tube disposed about the fiber bundle, in accordance with embodiments described in the disclosure.



FIG. 12 is a cross-sectional illustration of the elastic tube showing the elastic tube in a non-expanded, relaxed condition, and in an expanded condition as disposed on the fiber bundle, in accordance with embodiments described in the disclosure.



FIG. 13 is an illustration of the elastic tube disposed about the fiber bundle and introduced into the housing, in accordance with embodiments described in the disclosure.



FIG. 14 is an illustration of a method of manufacturing the blood processing apparatus, in accordance with embodiments described in the disclosure.



FIG. 15 is an illustration of a method of pre-cleaning the elastic tube used in the blood processing apparatus, in accordance with embodiments described in the disclosure.





Embodiments have been shown by way of example in the drawings and are described in detail below. The intention is not to limit the disclosure to the particular embodiments described. On the contrary, the disclosure is intended to cover all modifications, equivalents, and alternatives falling within the scope of the disclosure as defined by the appended claims.


DETAILED DESCRIPTION

The disclosure describes a blood processing apparatus that, according to some embodiments, includes a heat exchanger and a gas exchanger. The blood processing apparatus can be used in an extracorporeal blood circuit, such as that used in a cardiopulmonary bypass procedure, which includes several different elements, such as a pump, a blood reservoir, and an oxygenator. In some embodiments, the term oxygenator refers to an integrated structure that combines a heat exchanger and a gas exchanger in a unitary device. In some embodiments, the heat exchanger and the gas exchanger are disposed concentrically with one component situated inside the other component. In some embodiments, the heat exchanger and the gas exchanger are structurally distinct structures operably coupled to each other.


The disclosure describes a blood processing apparatus that includes a gas exchanger that includes an elastic tube disposed about a fiber bundle of gas exchanger hollow fibers. The elastic tube is situated about the fiber bundle to elastically constrain and protect the gas exchanger hollow fibers.


In some embodiments, the fiber bundle is wrapped around a shell and the elastic tube, the fiber bundle, and the shell are situated in a housing that includes a blood inlet and a blood outlet. The shell receives blood through the blood inlet and includes a surface and at least one aperture extending through the surface to permit the blood to flow to an exterior of the shell and the fiber bundle. Gas flows through the gas exchanger hollow fibers and blood flows across the gas exchanger hollow fibers to oxygenate the blood and remove carbon dioxide from the blood. The elastic tube has a pore size that permits the blood to flow across the elastic tube and out of the blood outlet without filtering micro-emboli from the blood. In some embodiments, the elastic tube/fiber bundle/shell assembly is introduced into the housing as a single unit. In some embodiments, the blood processing apparatus includes a heat exchanger situated in the housing and configured to receive blood and regulate the temperature of the blood.



FIG. 1 is a schematic illustration of a blood processing apparatus or oxygenator 10, in accordance with embodiments described in the disclosure. While some of the internal components of the blood processing apparatus 10 are not visible in this illustration, the blood processing apparatus 10 includes a gas exchanger that includes an elastic tube 8, indicated in dashed lines. The elastic tube 8 is disposed about a fiber bundle that includes gas exchanger hollow fibers that are used to oxygenate the blood and remove carbon dioxide from the blood. The elastic tube 8 is situated about the fiber bundle to elastically constrain and protect the gas exchanger hollow fibers. Also, the elastic tube 8 has a pore size that permits the blood to flow across the elastic tube 8 without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow.


The blood processing apparatus 10 includes a housing 12, a first end cap 14 that is secured to the housing 12, and a second end cap 16 that is secured to the housing 12. The gas exchanger, including the elastic tube 8 and the fiber bundle, is situated in the housing 12. In some embodiments, the blood processing apparatus 10 includes a heat exchanger. In some embodiments, the blood processing apparatus 10 includes a heat exchanger and the heat exchanger and the gas exchanger are integrated into a single structure. In some embodiments, the housing 12 includes other structure that enables attachment of the housing 12 to other devices.


While the housing 12 is illustrated as largely cylindrical in shape, in some embodiments the housing 12 has another shape, such as a cuboid shape, a triangular prism shape, or a hexagonal prism shape. Also, in some embodiments, the gas exchanger has the same shape or a different shape than the housing 12, and in some embodiments, a heat exchanger has the same shape or a different shape than the housing 12. In some embodiments, the blood processing apparatus 10 includes a heat exchanger and a gas exchanger, and the heat exchanger is situated inside of the gas exchanger. In some embodiments, the heat exchanger and the gas exchanger are concentrically aligned with one another.


The housing 12 and the first and second end caps 14 and 16 include a number of inlets and outlets for gas and fluid flow into the housing 12 and out of the housing 12, respectively. For blood flow, a blood inlet 18 extends into the housing 12 and a blood outlet 20 exits the housing 12. For gas flow, a gas inlet 22 extends into the housing 12 and a gas outlet 24 exits the housing 12 and, in embodiments that include a heat exchanger, for heat exchanger fluid, a heat exchanger fluid inlet 26 extends into the housing 12 and a heat exchanger fluid outlet 28, which is behind the heat exchanger fluid inlet 26 in FIG. 1, exits the housing 12. In some embodiments, the heat exchanger fluid inlet 26 is disposed at one end of the housing 12 and the heat exchanger fluid outlet 28 is disposed at an opposite end of the housing 12. In some embodiments, the blood processing apparatus 10 includes a purge port 30 that operates to permit gases, e.g., air bubbles, which exit the blood to be vented or aspirated and removed from the blood processing apparatus 10. In some embodiments, the purge port 30 includes a valve or a threaded cap.


The positions of the inlets 18, 22, and 26, the outlets 20, 24, and 28, and the purge port 30 are merely illustrative, as other arrangements and configurations are contemplated.



FIGS. 2 and 3 illustrate the first end cap 14 and the second end cap 16, respectively, in accordance with embodiments described in the disclosure. The first end cap 14 and the second end cap 16 are each configured to be secured to the housing 12. In some embodiments, the first end cap 14 and/or the second end cap 16 are adhesively secured in place. In some embodiments, the first end cap 14 and/or the second end cap 16 are snap-fit into place or threaded onto their respective ends of the housing 12.



FIG. 2 is an illustration of the first end cap 14, in accordance with embodiments described in the disclosure. While the first end cap 14 is illustrated as a standalone part, i.e., not attached to the housing 12, the position of the outer circumference of the elastic tube 8 in the blood processing apparatus 10 of FIG. 1 is indicated in dashed lines for reference.


In some embodiments, the blood inlet 18 and/or the gas inlet 22 are integrally formed with the first end cap 14. For example, in some embodiments, the first end cap 14 can be injection molded with the blood inlet 18 and/or the gas inlet 22 formed as part of the injection molded part. In some embodiments, the first end cap 14 can be formed having apertures to which the blood inlet 18 and/or the gas inlet 22 are attached.


The first end cap 14 includes an annular ring 32 that is disposed about a periphery of the first end cap 14 and that serves, in some embodiments, as an attachment point for securing the first end cap 14 to the housing 12. In some embodiments, the first end cap 14 also includes an annular ring 34 that locates portions of a heat exchanger.



FIG. 3 is an illustration of the second end cap 16, in accordance with embodiments described in the disclosure. While the second end cap 16 is illustrated as a standalone part, i.e., not attached to the housing 12, the position of the outer circumference of the elastic tube 8 in the blood processing apparatus 10 of FIG. 1 is indicated in dashed lines for reference.


In some embodiments, a heat exchanger fluid inlet 26 and/or a heat exchanger fluid outlet 28 are integrally formed with the second end cap 16. For example, in some embodiments, the second end cap 16 can be injection molded with the heat exchanger fluid inlet 26 and/or the heat exchanger fluid outlet 28 formed as part of the injection molded part. Also, in some embodiments, the second end cap 16 can be injected molded with the gas outlet 24 formed as part of the injection molded part. In some embodiments, the second end cap 16 can be formed having apertures to which one or more of the heat exchanger fluid inlet 26, the heat exchanger fluid outlet 28, and/or the gas outlet 24 are attached.


The second end cap 16 includes an annular ring 36 that is disposed about a periphery of the second end cap 16 and that serves, in some embodiments, as an attachment point for securing the second end cap 16 to the housing 12. In some embodiments, the second end cap 16 also includes an annular ring 38 that locates portions of a heat exchanger.


In some embodiments, one of the heat exchanger fluid inlet 26 and the heat exchanger fluid outlet 28 is located in the first end cap 14 and the other of the heat exchanger fluid inlet 26 and the heat exchanger fluid outlet 28 is located in the second end cap 16. Also, in some embodiments, the heat exchanger fluid inlet 26 and outlet 28 can be located in the first end cap 14.



FIG. 4 is a perspective illustration of a heat exchanger core 40, in accordance with embodiments described in the disclosure. The heat exchanger core 40 has a first end 42 and a second end 44. In some embodiments, the heat exchanger core 40 is disposed within the blood processing apparatus 10 such that the first end 42 is near the first end cap 14 and the second end 44 is near the second end cap 16. The heat exchanger core 40 includes an annular portion 46 that, in some embodiments, helps to locate the first end 42 relative to the first end cap 14. Also, in some embodiments, the second end 44 is configured to help locate the second end 44 relative to the second end cap 16. While the heat exchanger core 40 is illustrated as largely cylindrical in shape, in some embodiments the heat exchanger core 40 has another shape, such as a cuboid shape, a triangular prism shape, or a hexagonal prism shape.


The heat exchanger core 40 includes a conical deflection surface 48 upon which incoming blood, from the blood inlet 18, impinges. The conical deflection surface 48 deflects the blood in a radial direction. In some embodiments, the conical deflection surface 48 includes a divider 50 that assists in directing blood in particular directions.


The heat exchanger core 40 includes an outer surface 52. A core aperture 54 is formed within the outer surface 52, such that blood impinging on the conical deflection surface 48 is deflected radially outwardly through the core aperture 54. In some embodiments, the heat exchanger core 40 has one, two, three, or more core apertures 54 spaced radially about the heat exchanger core 40.


The heat exchanger core 40 includes a first radially disposed core rib 56 and a second radially disposed core rib 58. The core ribs (or projections) 56 and 58 deflect blood away from the outer surface 52 in a radially outward direction and impart a radial component to blood flow trajectory. The heat exchanger core 40 also includes longitudinally extending ribs 60 that serve to promote longitudinal flow paths down the outside of the heat exchanger core 40. In some embodiments, the heat exchanger core 40 includes more than two core ribs 56 and 58. In some embodiments, the ribs 56 and 58 extend circumferentially around or substantially around the outer surface of the heat exchanger core 40.



FIG. 5A is a perspective illustration of a cylindrical shell 62 that forms at least a partial barrier between the heat exchanger core 40 and a gas exchanger, in accordance with embodiments described in the disclosure. FIG. 5B is a cross-sectional illustration of the cylindrical shell 62 of FIG. 5A, in accordance with embodiments described in the disclosure. In some embodiments, the heat exchanger core 40 of FIG. 4 is disposed within the cylindrical shell 62 and arranged coaxially with the cylindrical shell 62, as shown in FIG. 6. In some embodiments, the cylindrical shell 62 is disposed within the housing 12 and arranged coaxially with the housing 12, as shown in FIG. 7. While the shell 62 is illustrated as largely cylindrical in shape, in some embodiments the shell 12 has another shape, such as a cuboid shape, a triangular prism shape, or a hexagonal prism shape.


The cylindrical shell 62 includes a first end 64 and a second end 66. In some embodiments, the cylindrical shell 62 is disposed within the housing 12 such that the first end 64 is near the first end cap 14 and the second end 66 is near the second end cap 16.


The cylindrical shell 62 also includes an exterior or outer surface 68. A shell aperture 70 is formed in the outer surface 68 such that blood flowing between the outer surface 52 of the heat exchanger core 40 and an inner surface 72 of the cylindrical shell 62 can exit the cylindrical shell 62 through the shell aperture 70 to the outer surface 68. In some embodiments, the cylindrical shell 62 has one, two, three, four, or more shell apertures 70 spaced radially about the cylindrical shell 62.


In some embodiments, the inner surface 72 of the cylindrical shell 62 includes one or more shell ribs 80 that protrude from the inner surface 72 and extend toward the heat exchanger core 40. These shell ribs 80 deflect blood away from the inner surface 72 in a radially inward direction. In some embodiments, the one or more shell ribs 80, in combination with the core ribs 56 and 58, interrupt longitudinal blood flow and impart a radial flow component to blood flow through the heat exchanger, i.e., between the outer surface 52 of the heat exchanger core 40 and the inner surface 72 of the cylindrical shell 72. In some embodiments, the heat exchanger core 40 includes one or more longitudinally extending ribs 75 that promote longitudinal flow paths between the heat exchanger core 40 and the cylindrical shell 62.



FIG. 6 is a perspective illustration of the heat exchanger core 40 of FIG. 4 disposed within the cylindrical shell 62 of FIG. 5, in accordance with embodiments described in the disclosure. The core aperture(s) 54 and the shell aperture(s) 70 are disposed at opposite ends of the blood processing apparatus 10, such that blood entering the volume between the outer surface 52 of the heat exchanger core 40 and the inner surface 72 of the cylindrical shell 62 is forced to flow substantially the entire length of the blood processing apparatus 10 before exiting the cylindrical shell 62.



FIG. 7 is a cross-sectional illustration of the blood processing apparatus 10 of FIG. 1, in accordance with embodiments described in the disclosure. The blood processing apparatus 10 includes the heat exchanger core 40 of FIG. 4 situated inside the cylindrical shell 62 of FIGS. 5A and 5B. The cylindrical shell 62 is situated inside the housing 12. Also, the heat exchanger core 40 is coaxially aligned with the cylindrical shell 62, which is coaxially aligned with the housing 12.


The blood processing apparatus 10 includes a heat exchanger element 74 disposed between the heat exchanger core 40 and the cylindrical shell 62. Also, the blood processing apparatus 10 includes a gas exchanger element 76 disposed between the cylindrical shell 62 and the housing 12. The elastic tube 8 is disposed about the gas exchanger element 76.


In some embodiments, the heat exchanger element 74 includes a number of hollow fibers through which a heating fluid, such as water, can flow. The blood flows around and past the hollow fibers to regulate the temperature of the blood. In some embodiments, the hollow fibers are polymeric. In some embodiments, the hollow fibers are metallic fibers. In some embodiments, the hollow fibers can be formed of polyurethane, polyester, or other suitable polymer or plastic material. In some embodiments, the hollow fibers have an outer diameter of between 0.2 and 1.0 millimeters, and in some embodiments, the hollow fibers have an outer diameter of between 0.25 and 0.5 millimeters.


The heat exchanger hollow fibers can be woven into mats that can range, for example, from 80 to 200 millimeters in width. In some embodiments, the mats are arranged in a criss-cross configuration. In some embodiments, the mats may be arranged parallel to each other. In other embodiments, the heat exchanger element 74 can include a metal bellows or other structure having a substantial surface area, e.g., fins, for facilitating heat transfer with the blood.


The gas exchanger element 76 includes a number of micro-porous hollow fibers through which a gas, such as oxygen, can flow. The micro-porous hollow fibers are situated on and about the outer surface 68 of the cylindrical shell 62 to provide a fiber bundle 78 on the cylindrical shell 62. The blood flows around and past the micro-porous hollow fibers and, due to concentration gradients, oxygen diffuses through the hollow fibers and into the blood and carbon dioxide diffuses out of the blood and into the hollow fibers. In some embodiments, the micro-porous hollow fibers are wound around the cylindrical shell 62 to provide the fiber bundle 78 on the outer surface 68 of the cylindrical shell 62. In some embodiments, the micro-porous hollow fibers are woven into fiber mats that are wound around the cylindrical shell 62 to provide the fiber bundle 78 on the outer surface 68 of the cylindrical shell 62. In some embodiments, the micro-porous hollow fibers are woven into fiber mats that can range, for example, from 80 to 200 millimeters in width. In some embodiments, the fiber mats are woven in a criss-cross configuration.


In some embodiments, the micro-porous hollow fibers are made of polymethylpentene (PMP), a plasma breakthrough resistant material. In some embodiments, the micro-porous hollow fibers are made of other plasma breakthrough resistant materials. In some embodiments, the micro-porous hollow fibers have an outer diameter of about 0.38 millimeters. In some embodiments, the micro-porous hollow fibers have an outer diameter of between 0.2 and 1.0 millimeters, and in some embodiments, the micro-porous hollow fibers have an outer diameter of between 0.25 and 0.5 millimeters. In other embodiments, the micro-porous hollow fibers are made of polypropylene, polyester, or another suitable polymer or plastic material.


The elastic tube 8 is disposed about the gas exchanger element 76 to elastically constrain and protect the micro-porous hollow fibers of the fiber bundle 78. The elastic tube 8 has a pore size that is large enough to permit blood to flow across the elastic tube 8 without filtering micro-emboli from the blood and to provide a reduced hydraulic resistance to blood flow.


In some embodiments, the elastic tube 8 is situated about the fiber bundle 78 prior to insertion of an assembly, including the elastic tube 8, the fiber bundle 78, and the cylindrical shell 62, into the housing 12 of the blood processing apparatus 10. The elastic tube 8 elastically confines or constrains the micro-porous hollow fibers of the fiber bundle 78 and the elastic tube 8 protects the micro-porous hollow fibers of the fiber bundle 78 from being damaged as the assembly is introduced into the housing 12. This prevents subsequent leaks through the micro-porous hollow fibers. The elastic tube 8 is not removed from the blood processing apparatus 10, such that the elastic tube 8 remains in the housing 12 during storage and operation of the blood processing apparatus 10.



FIG. 8 is a longitudinal cross-sectional illustration of the blood processing apparatus 10 of FIG. 1, in accordance with embodiments described in the disclosure. The heat exchanger core 40 is centrally located, with the heat exchanger element 74 coaxially disposed about the heat exchanger core 40. The cylindrical shell 62 is coaxially disposed about the heat exchanger element 74. The gas exchanger element 76 is coaxially disposed about the cylindrical shell 62 to provide the fiber bundle 78 about the outer surface 68 of the cylindrical shell 62. The elastic tube 8 is disposed about the fiber bundle 78, and the housing 12 is coaxially disposed about the elastic tube 8 and the other components. In some embodiments, the heat exchanger core 40 has core ribs 56 and 58 that impart a radial component to blood flow trajectory across the heat exchanger element 74. In some embodiments, the cylindrical shell 62 has radially disposed shell ribs 80 that are configured to impart a radial component to blood flow trajectory across the heat exchanger element 74.


In operation, blood enters the blood processing apparatus 10 through the blood inlet 18 and is radially directed through the core aperture(s) 54, such that the blood flows over and around the hollow fibers within the heat exchanger element 74. At least some of the blood flow impinges on the inner surface 72 of the cylindrical shell 62 and is radially directed back towards the outer surface 52 of the heat exchanger core 40, and at least some of the blood flow is directed radially outwards by the core ribs 56 and 58. The blood continues traveling back and forth radially until it reaches the shell aperture(s) 70. The blood flows through the shell aperture(s) 70 and over and around the micro-porous hollow fibers of the fiber bundle 78 in the space between the cylindrical shell 62 and the housing 12. The blood also flows through the elastic tube 8, which has a pore size that is large enough to permit the blood to flow across the elastic tube 8 without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow. The blood exits the blood processing apparatus 10 through the blood outlet 20.



FIG. 9 is an illustration of the elastic tube 8 in a flattened, relaxed condition, prior to being disposed on the fiber bundle 78 of the blood processing apparatus 10, in accordance with embodiments described in the disclosure.


The elastic tube 8 is made from an elastomeric yarn that elastically expands to be disposed about the fiber bundle 78. In some embodiments, the elastomeric yarn includes an inner core of a polyurethane elastic fiber covered with a nylon yarn. In some embodiments, the elastomeric yarn includes an inner core of spandex or elastane covered with a nylon yarn. In some embodiments, a coating is applied to the elastomeric yarn to decrease the contact angle of the surfaces and improve the wettability of the elastic tube 8.


The elastic tube 8 is produced by knitting the elastomeric yarn into the shape of a tube or sock. In some embodiments, the elastic tube 8 is knit on a circular machine, similar to a circular machine that produces socks. In some embodiments, the elastic tube 8 can be weaved into the shape of a tube or sock.



FIG. 10 is a microscopic enlarged illustration of a portion of the elastic tube 8, in accordance with embodiments described in the disclosure. The elastic tube 8 includes a fiber web 82 having pores 84 through which blood can flow. The size of the pores 84, referred to as the pore size, is measured by applying a best fit circle, such as circle 86, to the pores 84 of the elastic tube 8. The diameter D of the best fit circles are a measure of the pore sizes.


The elastic tube 8 is made to provide a pore size that permits the blood to flow across the fiber web without filtering micro-emboli from the blood and to reduce the hydraulic resistance of blood flow across the elastic tube 8 through the pores 84. The micro-emboli, including blood clots and bubbles, as measured by a best fit circle technique, have diameters of less than 120 micrometers. The elastic tube 8 is made to provide no significant filtering of solid or gaseous micro-emboli of less than 120 micrometers in diameter of a best fit circle.


In some embodiments, the pores 84 have an average pore size diameter with a best fit circle of 350 micrometers. In some embodiments, the pores 84 have an average pore size diameter with a best fit circle in a range of from 200 to 500 micrometers. In some embodiments, the pores 84 have an average pore size diameter with a best fit circle in a range of from 150 to 800 micrometers. In some embodiments, the pores 84 have an average pore size diameter with a best fit circle of greater than 200 micrometers.



FIG. 11 is an illustration of the elastic tube 8 disposed about the fiber bundle 78, in accordance with embodiments described in the disclosure. The elastic tube 8 expands to fit around the fiber bundle 78 on the cylindrical shell 62. In some embodiments, the elastic tube 8 fits around at least a portion of one or both ends 88 and 90 of the fiber bundle 78, which can help to secure the elastic tube 8 on the fiber bundle 78.



FIG. 12 is a cross-sectional illustration of the elastic tube 8 showing the elastic tube 8 in a non-expanded, relaxed condition at 92, and in an expanded condition at 94 (as disposed on the fiber bundle 78), in accordance with embodiments described in the disclosure. The elastic tube 8 expands in the radial direction R to be disposed on the fiber bundle 78. In the expanded condition at 94, the elastic tube 8 has a diameter L1 and in the non-expanded, relaxed condition at 92, the elastic tube 8 has a diameter L2. In some embodiments, the ratio of the diameters L2/L1 is less than 0.5.


The elastic tube 8 has a tube interior 96 and a tube exterior 98. In the expanded condition at 94, when disposed on the fiber bundle 78 and situated in the blood processing apparatus 10, the fiber bundle 78 is situated next to the tube interior 96 and the housing 12 is situated next to the tube exterior 98.



FIG. 13 is an illustration of the elastic tube 8 disposed about the fiber bundle 78 and introduced into the housing 12, in accordance with embodiments described in the disclosure. As previously described, the elastic tube 8 is disposed about the gas exchanger element 76 to elastically constrain and protect the micro-porous hollow fibers of the fiber bundle 78. Also, the elastic tube 8 has a pore size that is large enough to permit blood to flow across the elastic tube 8, from the tube interior 96 to the tube exterior 98, without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow. The elastic tube 8 is not removed from the blood processing apparatus 10, such that the elastic tube 8 remains in the housing 12 during storage and operation of the blood processing apparatus 10. In some embodiments, the elastic tube 8 is situated about the fiber bundle 78 prior to insertion of the assembly, including the elastic tube 8, the fiber bundle 78, and the cylindrical shell 62, into the housing 12 of the blood processing apparatus 10.



FIG. 14 is an illustration of a method of manufacturing the blood processing apparatus 10, in accordance with embodiments described in the disclosure.


At 100, the method includes providing gas exchanger micro-porous hollow fibers. The gas exchanger 74 includes micro-porous hollow fibers that blood flows around and past for oxygenating the blood and removing carbon dioxide from the blood. In some embodiments, the micro-porous hollow fibers are made of plasma breakthrough resistant PMP hollow fibers. In other embodiments, the micro-porous hollow fibers are made of polypropylene, polyester, or another suitable polymer or plastic material.


At 102, the method includes winding the micro-porous hollow fibers onto the cylindrical shell 62 to provide the fiber bundle 78. The micro-porous hollow fibers are situated on and about the exterior surface of the cylindrical shell 62 to provide the fiber bundle 78 on the cylindrical shell 62. In some embodiments, the micro-porous hollow fibers are woven into fiber mats that are wound about the cylindrical shell 62 to provide the fiber bundle 78. In other embodiments, the shell 62 is not cylindrical, but another shape, such as cuboid shaped, triangular prism shaped, or hexagonal prism shaped.


At 104, the method includes providing the elastic tube 8 including the fiber web 82 that permits blood to flow across the fiber web 82 without filtering micro-emboli from the blood. In some embodiments, providing the elastic tube 8 includes knitting an elastomeric yarn to provide the elastic tube 8. In some embodiments, providing the elastic tube 8 includes knitting an elastomeric yarn to provide the elastic tube 8 using a circular machine.


At 106, the method includes introducing the fiber bundle 78 and the cylindrical shell 62 into the elastic tube 8. The elastic tube 8 elastically constrains and protects the micro-porous hollow fibers of the fiber bundle 78. Also, the elastic tube 8 has a pore size that is large enough to permit blood to flow across the elastic tube 8, from the tube interior 92 to the tube exterior 94, without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow.


At 108, the method includes introducing the elastic tube 8 containing the fiber bundle 78 and the cylindrical shell 62 into the housing 12, such that the fiber web 82 elastically constrains the gas exchanger hollow fibers and protects the gas exchanger hollow fibers from being damaged by the housing 12. The elastic tube 8 is not removed from the blood processing apparatus 10, such that the elastic tube 8 remains in the housing 12 during storage and operation of the blood processing apparatus 10.



FIG. 15 is an illustration of a method of cleaning the elastic tube 8 prior to assembling the blood processing apparatus 10, in accordance with embodiments described in the disclosure. The method includes, washing the elastic tube 8 with a solvent at 120, washing the elastic tube 8 with purified water at 122, and sterilizing the elastic tube 8 with steam sterilization at 124. Then the elastic tube 8 can be used in the blood processing apparatus 10.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present disclosure. For example, while the embodiments described above refer to particular features, the scope of the disclosure also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present disclosure is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. A blood processing apparatus comprising: a housing having a blood inlet and a blood outlet;a shell situated in the housing and configured to receive blood through the blood inlet and including a surface and one or more apertures extending through the surface to permit the blood to flow to an exterior of the shell;a fiber bundle including gas exchanger hollow fibers situated about the shell such that gas flows through the gas exchanger hollow fibers and the blood flows across the gas exchanger hollow fibers; andan elastic tube including a fiber web situated about the fiber bundle and configured to elastically constrain and protect the gas exchanger hollow fibers during insertion into the housing, the fiber web having an average pore size diameter with a best fit circle in a range of from 150 to 800 micrometers such that the fiber web permits the blood to flow across the fiber web without filtering micro-emboli from the blood, wherein a ratio (L2/L1) of a diameter of the elastic tube in an unexpanded state (L2) to a diameter of the elastic tube in an expanded state (L1) disposed on the fiber bundle is less than 0.5.
  • 2. The blood processing apparatus of claim 1, wherein the fiber web has an average pore size diameter with a best fit circle of 350 micrometers.
  • 3. The blood processing apparatus of claim 1, wherein the fiber web has an average pore size diameter with a best fit circle in a range of from 200 to 500 micrometers.
  • 4. The blood processing apparatus of claim 1, wherein the fiber web has an average pore size diameter with a best fit circle of greater than 200 micrometers.
  • 5. The blood processing apparatus of claim 1, wherein the fiber web permits the blood to flow across the fiber web without filtering solid and gaseous micro-emboli of less than 120 micrometers in diameter of a best fit circle.
  • 6. The blood processing apparatus of claim 1, wherein the fiber web permits the blood to flow across the fiber web without filtering solid and gaseous micro-emboli including blood clots and bubbles.
  • 7. The blood processing apparatus of claim 1, wherein the fiber web permits the blood to flow across the fiber web without filtering solid and gaseous micro-emboli otherwise captured by average pore sizes of between 20 and 120 micrometers.
  • 8. The blood processing apparatus of claim 1, wherein the elastic tube includes an elastomeric yarn.
  • 9. The blood processing apparatus of claim 1, wherein the elastic tube includes a knit weave of elastomeric yarn.
  • 10. The blood processing apparatus of claim 1, wherein the elastic tube includes an elastomeric yarn that includes an inner core of polyurethane elastic fiber covered with a nylon yarn.
  • 11. The blood processing apparatus of claim 1, wherein the fiber web includes a coating of a wetting agent to decrease contact angles of surfaces and improve wettability.
  • 12. The blood processing apparatus of claim 1, wherein the elastic tube extends at least partially around at least one end of the fiber bundle.
  • 13. A blood processing apparatus comprising: a housing having a blood inlet and a blood outlet;a heat exchanger situated in the housing and configured to receive blood through the blood inlet and regulate the temperature of the blood;a shell situated about the heat exchanger and including a surface and one or more apertures extending through the surface to permit the blood to flow to an exterior of the shell;a fiber bundle including gas exchanger hollow fibers situated about the shell such that gas flows through the gas exchanger hollow fibers and the blood flows across the gas exchanger hollow fibers; andan elastic tube having a tube interior and a tube exterior such that the fiber bundle is situated in the tube interior and the tube exterior is situated next to the housing and the elastic tube elastically constrains and protects the gas exchanger hollow fibers as the fiber bundle and the elastic tube are introduced into the housing and maintained in the housing, wherein the elastic tube has an average pore size diameter with a best fit circle in a range from 150 to 800 micrometers that permits the blood to flow from the tube interior to the tube exterior without filtering micro-emboli from the blood and with a reduced hydraulic resistance to blood flow, wherein a ratio (L2/L1) of a diameter of the elastic tube in an unexpanded state (L2) to a diameter of the elastic tube in an expanded state (L1) disposed on the fiber bundle is less than 0.5.
  • 14. The blood processing apparatus of claim 13, wherein the elastic tube has an average pore size diameter with a best fit circle of 350 micrometers to provide a reduced hydraulic resistance to blood flow.
  • 15. The blood processing apparatus of claim 13, wherein the elastic tube has an average pore size diameter with a best fit circle of 500 micrometers or less to provide a reduced hydraulic resistance to blood flow.
  • 16. The blood processing apparatus of claim 13, wherein the elastic tube permits the blood to flow from the tube interior to the tube exterior without filtering solid and gaseous micro-emboli otherwise captured by average pore sizes of between 20 and 120 micrometers.
  • 17. The blood processing apparatus of claim 13, wherein the elastic tube permits the blood to flow from the tube interior to the tube exterior without filtering solid and gaseous micro-emboli including blood clots and bubbles.
  • 18. The blood processing apparatus of claim 13, wherein the gas exchanger hollow fibers include plasma resistant polymethylpentene (PMP) hollow fibers.
  • 19. A method of manufacturing a blood processing apparatus comprising: providing gas exchanger hollow fibers;winding the gas exchanger hollow fibers onto a shell to provide a fiber bundle on the shell;providing an elastic tube including a fiber web having an average pore size diameter with a best fit circle in a range of from 150 to 800 micrometers that permits blood to flow across the fiber web without filtering micro-emboli from the blood, wherein a ratio (L2/L1) of a diameter of the elastic tube in an unexpanded state (L2) to a diameter of the elastic tube in an expanded state (L1) disposed on the fiber bundle is less than 0.5;introducing the fiber bundle and the shell into the elastic tube; andintroducing the elastic tube containing the fiber bundle and the shell into a housing such that the fiber web elastically constrains the gas exchanger hollow fibers and protects the gas exchanger hollow fibers from being mechanically damaged by the housing.
  • 20. The method of claim 19, comprising maintaining the elastic tube in the housing prior to and during use of the blood processing apparatus.
  • 21. The method of claim 19, wherein providing gas exchanger hollow fibers and winding the gas exchanger hollow fibers onto a shell comprises: providing plasma resistant polymethylpentene (PMP) hollow fibers; andwinding the plasma resistant polymethylpentene (PMP) hollow fibers onto the shell.
  • 22. The method of claim 19, wherein providing an elastic tube comprises: knitting an elastomeric yarn to provide the elastic tube.
  • 23. The method of claim 19, wherein providing an elastic tube comprises: knitting an elastomeric yarn to provide the elastic tube using a circular machine.
PCT Information
Filing Document Filing Date Country Kind
PCT/IB2014/065987 11/12/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2016/075514 5/19/2016 WO A
US Referenced Citations (89)
Number Name Date Kind
3339341 Murdock Sep 1967 A
3957648 Roget et al. May 1976 A
4038190 Baudet et al. Jul 1977 A
4225439 Spranger Sep 1980 A
4229305 Fecondini et al. Oct 1980 A
4597868 Watanabe Jul 1986 A
4639353 Takemura et al. Jan 1987 A
4707268 Shah et al. Nov 1987 A
4758341 Banner Jul 1988 A
4902476 Gordon et al. Feb 1990 A
5169530 Schucker et al. Dec 1992 A
5192439 Roth et al. Mar 1993 A
5192499 Sakai et al. Mar 1993 A
5270004 Cosentino et al. Dec 1993 A
5316724 Mathewson et al. May 1994 A
5338512 Mathewson et al. Aug 1994 A
5514095 Brightbill et al. May 1996 A
5578267 Cosentino et al. Nov 1996 A
5651765 Haworth et al. Jul 1997 A
5674452 Carson et al. Oct 1997 A
5733398 Carson et al. Mar 1998 A
5762868 Leonard Jun 1998 A
5762869 White et al. Jun 1998 A
5817278 Fini et al. Oct 1998 A
5817279 Eilers et al. Oct 1998 A
5830370 Maloney, Jr. et al. Nov 1998 A
RE36774 Cosentino et al. Jul 2000 E
6105664 Gillbrand et al. Aug 2000 A
6113782 Leonard Sep 2000 A
6241945 Owen Jun 2001 B1
6454999 Farhangia et al. Sep 2002 B1
6459937 Morgan et al. Oct 2002 B1
6755894 Bikson et al. Jun 2004 B2
6960322 Stringer et al. Nov 2005 B2
7431754 Ogihara et al. Oct 2008 B2
7947113 Ogihara et al. May 2011 B2
7981121 Stegfeldt et al. Jul 2011 B2
8142546 Ogihara et al. Mar 2012 B2
8318092 Reggiani et al. Nov 2012 B2
8388566 Reggiani et al. Mar 2013 B2
8394049 Reggiani et al. Mar 2013 B2
8425838 Mizoguchi et al. Apr 2013 B2
8652406 Reggiani et al. Feb 2014 B2
8685319 Olson et al. Apr 2014 B2
8795220 Reggiani et al. Aug 2014 B2
8865067 Olson et al. Oct 2014 B2
8911666 Mizoguchi et al. Dec 2014 B2
8980176 Reggiani et al. Mar 2015 B2
9162022 Reggiani et al. Oct 2015 B2
9402943 Reggiani et al. Aug 2016 B2
9566376 Kashefi Khorasani Feb 2017 B2
10098994 Silvestri et al. Oct 2018 B2
10159777 Reggiani et al. Dec 2018 B2
10322223 Ochel Jun 2019 B2
10369262 Reggiani Aug 2019 B2
20020039543 Ikeda et al. Apr 2002 A1
20020049401 Ghelli et al. Apr 2002 A1
20030080047 Watkins et al. May 2003 A1
20030175149 Searles et al. Sep 2003 A1
20040149645 Sunohara et al. Aug 2004 A1
20040175292 Ghellil et al. Sep 2004 A1
20040251011 Kudo Dec 2004 A1
20060016743 Ogihara et al. Jan 2006 A1
20070107884 Sirkar et al. May 2007 A1
20070166190 Ogihara et al. Jul 2007 A1
20070231203 Mizoguchi et al. Oct 2007 A1
20080234623 Strauss et al. Sep 2008 A1
20100106072 Kashefi-Khorasani et al. Apr 2010 A1
20100269342 Carpenter et al. Oct 2010 A1
20100272606 Carpenter et al. Oct 2010 A1
20100272607 Carpenter et al. Oct 2010 A1
20110268608 Reggiani et al. Nov 2011 A1
20110268609 Reggiani et al. Nov 2011 A1
20120046594 Reggiani et al. Feb 2012 A1
20120121463 Reggiani et al. May 2012 A1
20120294761 Reggiani Nov 2012 A1
20120308434 Kawamura Dec 2012 A1
20130142695 Reggiani et al. Jun 2013 A1
20130142696 Reggiani et al. Jun 2013 A1
20140030146 Takeuchi Jan 2014 A1
20140154137 Kashefi Khorasani Jun 2014 A1
20140227133 Reggiani et al. Aug 2014 A1
20150068670 Mizoguchi et al. Mar 2015 A1
20160325036 Silvestri et al. Nov 2016 A1
20160354529 Reggiani et al. Dec 2016 A1
20170072123 Reggiani Mar 2017 A1
20180133388 Mazzoli et al. May 2018 A1
20190091395 Reggiani et al. Mar 2019 A1
20190290821 Reggiano Sep 2019 A1
Foreign Referenced Citations (76)
Number Date Country
1042082 May 1990 CN
2511309 Sep 2002 CN
1308549 Sep 2005 CN
2772515 Apr 2006 CN
1907508 Feb 2007 CN
1914474 Feb 2007 CN
201510571 Jun 2010 CN
101837151 Sep 2010 CN
201978219 Sep 2011 CN
103180032 Jun 2013 CN
103328019 Sep 2013 CN
103547298 Jan 2014 CN
106029118 Oct 2016 CN
19782098 Nov 1999 DE
102007010112 Sep 2008 DE
102010027973 Oct 2011 DE
0170210 Feb 1986 EP
0312125 Apr 1989 EP
0582959 Feb 1994 EP
0895786 Feb 1999 EP
1108462 Jun 2001 EP
1180374 Feb 2002 EP
1371381 Dec 2003 EP
1618906 Jan 2006 EP
1834656 Sep 2007 EP
2420262 Feb 2012 EP
2524712 Nov 2012 EP
2537543 Dec 2012 EP
445526 Mar 1969 JP
S52126681 Oct 1977 JP
S59147603 Aug 1984 JP
60053156 Mar 1985 JP
S6178407 Apr 1986 JP
S63139562 Jun 1988 JP
S63283709 Nov 1988 JP
03169329 Jul 1991 JP
H042067 Jan 1992 JP
04-039862 Jun 1992 JP
H0439862 Jun 1992 JP
H05177117 Jul 1993 JP
H0788178 Apr 1995 JP
H08168525 Jul 1996 JP
H11508476 Jul 1999 JP
2000501954 Feb 2000 JP
2000093510 Apr 2000 JP
3228518 Nov 2001 JP
2002506692 Mar 2002 JP
3284568 May 2002 JP
2002306592 Oct 2002 JP
2003520617 Jul 2003 JP
2003525736 Sep 2003 JP
2004216143 Aug 2004 JP
2006034466 Feb 2006 JP
2007190218 Feb 2007 JP
2007244880 Sep 2007 JP
3992377 Oct 2007 JP
2007260151 Oct 2007 JP
2007328114 Dec 2007 JP
2009-093659 Apr 2009 JP
201147269 Mar 2011 JP
5020111 Sep 2012 JP
2012239885 Dec 2012 JP
201363121 Apr 2013 JP
2015144857 Aug 2015 JP
2017-510340 Apr 2017 JP
WO1997016213 May 1997 WO
WO1997019714 Jun 1997 WO
WO1997033636 Sep 1997 WO
W09947189 Sep 1999 WO
WO9958171 Nov 1999 WO
WO2010124087 Oct 2010 WO
2012066439 May 2012 WO
2012133372 Oct 2012 WO
2015104725 Jul 2015 WO
2015107486 Jul 2015 WO
2015128886 Sep 2015 WO
Non-Patent Literature Citations (20)
Entry
European Search Report issued in EP Application No. 10161451, dated Sep. 28, 2010, 5 pages.
European Search Report issued in EP Application No. 10173436, dated Feb. 14, 2011, 7 pages.
European Search Report issued in EP Application No. 10186550, dated Jan. 27, 2011, 7 pages.
European Search Report issued in EP Application No. 10191140, dated Nov. 30, 2011, 8 pages.
European Search Report issued in EP Application No. 12187501, dated Nov. 20, 2013, 6 pages.
European Search Report issued in EP Application No. 13161841, dated Jun. 11, 2013, 6 pages.
International Preliminary Report on Patentability issued in PCT/IB2014/065987, dated May 26, 2017, 9 pages.
International Preliminary Report on Patentability issued in PCT/IT2014/000005, dated Jul. 12, 2016, 6 pages.
International Preliminary Report on Patentability issued in PCT/IT2014/000058, dated Sep. 6, 2016, 10 pages.
International Search Report and Written Opinion issued in PCT/IB2012/052424, dated Oct. 24, 2012, 17 pages.
International Search Report and Written Opinion issued in PCT/IB2014/065987, dated Jul. 6, 2015, 10 pages.
International Search Report and Written Opinion issued in PCT/IT2014/000005, dated Sep. 26, 2014, 9 pages.
International Search Report and Written Opinion issued in PCT/IT2014/000058, dated Dec. 8, 2014, 14 pages.
International Search Report issued in PCT/IB2011/054725, dated Feb. 9, 2012, 12 pages.
Italian Search Report issued in IT Application No. IT MO20140010, completed Sep. 23, 2014, 7 pages.
International Preliminary Report on Patentability issued in PCT/IB2014/065987, dated May 16, 2017, 8 pages.
International Preliminary Report on Patentability issued in PCT/IB2015/053493, dated Nov. 23, 2017, 9 pages.
International Search Report and Written Opinion issued in PCT/IB2015/053493, dated Jan. 18, 2016, 13 pages.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/IB2012/052424, dated Nov. 28, 2013, 11 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/IT2014/000005, dated Sep. 26, 2014, 8 pages.
Related Publications (1)
Number Date Country
20170319767 A1 Nov 2017 US